Literature DB >> 19350332

Gabapentin versus tricyclics for neuropathic pain.

Alec B O'Connor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350332      PMCID: PMC2686764          DOI: 10.1007/s11606-009-0957-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  10 in total

1.  Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial.

Authors:  K C Gorson; C Schott; R Herman; A H Ropper; W M Rand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

2.  Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.

Authors:  C Dallocchio; C Buffa; P Mazzarello; S Chiroli
Journal:  J Pain Symptom Manage       Date:  2000-10       Impact factor: 3.612

Review 3.  Pharmacologic management of neuropathic pain: evidence-based recommendations.

Authors:  Robert H Dworkin; Alec B O'Connor; Miroslav Backonja; John T Farrar; Nanna B Finnerup; Troels S Jensen; Eija A Kalso; John D Loeser; Christine Miaskowski; Turo J Nurmikko; Russell K Portenoy; Andrew S C Rice; Brett R Stacey; Rolf-Detlef Treede; Dennis C Turk; Mark S Wallace
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

4.  Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.

Authors:  C M Morello; S G Leckband; C P Stoner; D F Moorhouse; G A Sahagian
Journal:  Arch Intern Med       Date:  1999-09-13

5.  Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.

Authors:  K Chandra; N Shafiq; P Pandhi; S Gupta; S Malhotra
Journal:  Int J Clin Pharmacol Ther       Date:  2006-08       Impact factor: 1.366

6.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Authors:  R Temple; S S Ellenberg
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

Review 7.  Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

Authors:  Michael A Steinman; Lisa A Bero; Mary-Margaret Chren; C Seth Landefeld
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

8.  Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials.

Authors:  Roger Chou; Susan Carson; Benjamin K S Chan
Journal:  J Gen Intern Med       Date:  2008-12-17       Impact factor: 5.128

Review 9.  Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.

Authors:  Miroslav Backonja; Robert L Glanzman
Journal:  Clin Ther       Date:  2003-01       Impact factor: 3.393

Review 10.  Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.

Authors:  Isabelle Boutron; Candice Estellat; Lydia Guittet; Agnes Dechartres; David L Sackett; Asbjørn Hróbjartsson; Philippe Ravaud
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.